Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL) will present multiple abstracts on its MASH treatment Rezdiffra at the European Association for the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE